Related Experiment Videos

Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients

K H Moon1, I S Song, W S Yang

  • 1Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.

American Journal of Nephrology
|November 28, 2000
PubMed

Insights

Left-ventricular hypertrophy (LVH) is common in patients starting hemodialysis. Low serum albumin levels were identified as a significant risk factor for the progression of LVH in these patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Left-ventricular hypertrophy (LVH) is a significant concern in patients with end-stage renal disease (ESRD) undergoing maintenance hemodialysis.
  • Understanding the progression of LVH and its associated risk factors is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate changes in left-ventricular (LV) mass in patients initiating maintenance hemodialysis.
  • To identify risk factors contributing to the progression of LVH in this population.

Main Methods:

  • Baseline echocardiography was performed on 111 ESRD patients within six months of starting hemodialysis.
  • Follow-up echocardiography was conducted on 32 patients with baseline LVH after approximately 15 months.
  • LVH was defined by left-ventricular mass index (LVMI); progressive LVH was defined as >105% of baseline LVMI.

Main Results:

  • A high prevalence of LVH (82%) was observed in patients starting hemodialysis.
  • Progressive LVH occurred in 19 of 32 patients (59%).
  • Lower diastolic blood pressure and lower serum albumin levels were associated with progressive LVH; hypoalbuminemia was an independent risk factor.

Conclusions:

  • LVH is highly prevalent among ESRD patients initiating maintenance hemodialysis.
  • A substantial proportion of patients experienced LVH progression, with hypoalbuminemia identified as a key risk factor.
  • Further research into managing hypoalbuminemia may help mitigate LVH progression in dialysis patients.
Abstract

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...